Comparison results
Results: Differences Similar | ✘Oligodendroglioma | ✘Aura | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 90% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
oncology | 35% | — | ||||||||||
pulsates | — | 33% | ||||||||||
brain tumor | 34% | — | ||||||||||
migraine status | — | 20% | ||||||||||
brain tumors | 30% | — | ||||||||||
headache with nausea | — | 15% | ||||||||||
cancer | 29% | — | ||||||||||
headache vomiting | — | 12% | ||||||||||
main complaint headache | 29% | — | ||||||||||
dizziness from odors | — | 8% | ||||||||||
women passion | 27% | — | ||||||||||
epilepsy in childhood | — | 7% | ||||||||||
irradiation | 26% | — | ||||||||||
convulsions in the anamnesis | — | 7% | ||||||||||
very pale | 25% | — | ||||||||||
lack of taste | — | 7% | ||||||||||
headache attacks | 23% | — | ||||||||||
anxiety in the stomach | — | 7% | ||||||||||
oncology relatives | 23% | — | ||||||||||
dizziness with fever | — | 6% | ||||||||||
speech absence | 22% | — | ||||||||||
dizziness with excitement | — | 6% | ||||||||||
heredity predisposition | 20% | — | ||||||||||
absences | — | 6% | ||||||||||
irritability | 19% | — | ||||||||||
Fever anxiety | — | 5% | ||||||||||
radiation therapy | 19% | — | ||||||||||
senestopathy | — | 5% | ||||||||||
visual impairment | 19% | — | ||||||||||
focal epilepsy | — | 5% | ||||||||||
preschool age | 18% | — | ||||||||||
abdominal discomfort | — | 4% | ||||||||||
consequences of operation | 17% | — | ||||||||||
unspecified mental disorders | — | 4% | ||||||||||
headaches | 17% | — | ||||||||||
sensations in the head | — | 4% | ||||||||||
impaired lung function | 17% | — | ||||||||||
anxiety | — | 4% | ||||||||||
onset of illness | 16% | — | ||||||||||
dizziness | — | 4% | ||||||||||
there are no complaints | 16% | — | ||||||||||
perception | — | 4% | ||||||||||
consequences of taking medications | 15% | — | ||||||||||
nervous excitability | — | 4% | ||||||||||
epilepsy | 19% | 8% | ||||||||||
patient's condition | — | 4% | ||||||||||
epilepsy attacks | 20% | 9% | ||||||||||
sadness | — | 4% | ||||||||||
convulsions | 18% | 8% | ||||||||||
psychological suppression | — | 4% | ||||||||||
high temperature | — | 3% |
Instructions
Video
|